ClearLife Extra Strength Nasal Spray Recalled for Microbial Contamination
ClearLife Extra Strength nasal spray is recalled nationwide due to contamination with yeast, mold, and Achromobacter bacteria. Consumers should stop using the product immediately.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: FDA Class I classification applies to products posing serious adverse-health-consequence risks. Non-sterile nasal spray with identified Achromobacter bacterial and yeast/mold contamination meets FDA Class I criteria, establishing a minimum severity floor of Severe.
Plain-English summary
ClearLife Extra Strength nasal spray (0.68 fl. oz./20 mL bottles, NDC 62795-4006-9) is being recalled nationwide. The product, manufactured by Medinatura New Mexico, inc., has been found to contain yeast, mold, and bacterial contamination identified as Achromobacter.
This is a non-sterile product applied directly to the nasal passages. Because of this route of administration and the presence of microbial contamination, the product poses a potential infection risk.
All lots within the product's expiration date are affected by this recall. Consumers who have purchased ClearLife Extra Strength nasal spray should stop using it immediately. Consumers with questions should contact the manufacturer or the FDA.
The recalled product
- Product
- CLEARLIFE EXTRA STRENGTH (ONION, GALPHIMIA GLAUCA FLOWERING TOP, HISTAMINE DIHYDROCHLORIDE, LUFFA OPERCULATA FRUIT, SULFUR, AMBROSIA ARTEMISIIFOLIA WHOLE, EUPHRASIA STRICTA AND SCHOENOCAULON OFFICINALE SEED)
- Brand
- CLEARLIFE EXTRA STRENGTH
- Manufacturer
- Medinatura New Mexico, inc.
- Category
- Drug — Nasal Spray
- Hazard
- achromobacter-contamination
- yeast-mold-contamination
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- All lots within expiry.
UPCs (1)
- 787647101887
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- ModerateGas-X Simethicone 125 mg softgels recall for incomplete labeling
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27